UMC119-06-05 / Xuanjie 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  UMC119-06-05 / Xuanjie
    New P1/2 trial:  Mesenchymal Stem Cells for Frailty Syndrome (clinicaltrials.gov) -  Jul 14, 2024   
    P1/2,  N=66, Active, not recruiting, 
  • ||||||||||  UMC119-06-05 / Xuanjie
    Trial completion date, Trial primary completion date:  Mesenchymal Stem Cells for The Treatment of Frailty Syndrome (clinicaltrials.gov) -  Dec 6, 2022   
    P1,  N=6, Recruiting, 
    Trial completion date: Jul 2023 --> Jul 2025 | Trial primary completion date: Dec 2022 --> Dec 2024
  • ||||||||||  UMC119-06-05 / Xuanjie
    Enrollment open, Trial completion date, Trial primary completion date:  Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA). (clinicaltrials.gov) -  Dec 6, 2022   
    P1,  N=6, Recruiting, 
    Trial completion date: Jul 2023 --> Jul 2025 | Trial primary completion date: Dec 2022 --> Dec 2024 Not yet recruiting --> Recruiting | Trial completion date: Jun 2023 --> Jun 2025 | Trial primary completion date: Sep 2022 --> Sep 2024
  • ||||||||||  UMC119-06-05 / Xuanjie
    Enrollment open:  Mesenchymal Stem Cells for The Treatment of Frailty Syndrome (clinicaltrials.gov) -  Apr 7, 2022   
    P1,  N=6, Recruiting, 
    Not yet recruiting --> Recruiting | Trial completion date: Jun 2023 --> Jun 2025 | Trial primary completion date: Sep 2022 --> Sep 2024 Not yet recruiting --> Recruiting